Antiseizure medications and their differing effects on cardiovascular risk
This review discusses the differing effects of enzyme-inducing and non-inducing antiseizure medications on cardiovascular risk and their implications for the management strategies of epilepsy patients. Traditional risk markers, including low density lipoprotein, high density lipoprotein and triglyce...
Saved in:
Main Authors: | Aleena Abbasi, Bassil Abbasi, Scott Mintzer, Carla LoPinto-Khoury |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Epilepsy & Behavior Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589986425000061 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A meta-analytic evaluation of the efficacy and safety of levetiracetam for treating myoclonic seizures
by: Sara Najafi, et al.
Published: (2025-02-01) -
Usefulness of perampanel as initial monotherapy in children with non-lesional focal epilepsy
by: Hideaki Kanemura, et al.
Published: (2025-03-01) -
Cerebrospinal fluid‐specific oligoclonal bands in dogs with idiopathic epilepsy
by: Junwei Föhr, et al.
Published: (2025-01-01) -
Multicentric study of adherence to antiseizure medications among adults with epilepsy attended in neurology departments in Burkina Faso
by: Alfred Anselme Dabilgou, et al.
Published: (2025-02-01) -
Antiseizure medication prescribing in people with Dravet syndrome: An analysis of real‐time administrative data
by: Kevin Y. Xu, et al.
Published: (2025-02-01)